Clinical Trial

Neurocognitive Trajectories After BCMA CAR-T

Name: Neurocognitive Trajectories After BCMA CAR-T — clinical trial record (NCT07740317)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAR-T Cog

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this research study is to evaluate cognitive changes over time in participants with relapsed or refractory multiple myeloma who have received chimeric antigen receptor T-cell therapy (CAR-T).

Trial Details

NCT Number	NCT07740317
Lead Sponsor	Wake Forest University Health Sciences Collaborators: Atrium Health Wake Forest Baptist
Conditions	Multiple Myeloma (MM), CART Therapy, Refractory Multiple Myeloma (RRMM)
Enrollment	50 participants
Start Date	2026-09
Primary Completion	2029-11 (estimated)
Study Completion	2029-11 (estimated)
Updated on ClinicalTrials.gov	2026-07-31